Home
Conditions
Lymphoproliferative Disorders

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,043 public trials 2,030 recruiting studies

Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma

NCT00388531

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Hospital "Santa Creu i Sant Pau" Barcelona, Spain

Hospital Clínico y Provincial de Barcelona Barcelona, Spain

Hospital Germans Trias i Pujol Barcelona, Spain

Hospital Clínico San Carlos de Madrid Madrid, Spain

View Trial Details

Completed

Bortezomib (Velcade) Post Allogenic Peripheral Blood Stem Cell Transplantation for Myeloma

NCT00504634

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Natural Killer Cells Function in Patients With Chronic Lymphocytic Leukemia

NCT00934986

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Institut PAOLI-CALMETTES Marseille, France

View Trial Details

Completed

Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years

NCT00307671

Conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Arteritis, Autoimmune Diseases, +25 more
Locations: Hôpital Cochin Paris, France

View Trial Details

Completed

A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT

NCT00791947

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations: Aarhus University Hospital Aarhus, Denmark

Copenhagen Hospital Copenhagen, Denmark

Vejle Hospital Vejle, Denmark

OULO University Hospital Oulu, Oulo, Finland

View Trial Details

Completed

UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple Myeloma

NCT00113932

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

View Trial Details

Completed

Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple Myeloma

NCT00118339

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chemically-Induced Disorders, +15 more
Locations: Fred Hutchinson Cancer Research Center Seattle, Washington, United States

View Trial Details

Completed

Lenalidomide, Cyclophosphamide, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma

NCT00478218

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Mayo Clinic Scottsdale Scottsdale, Arizona, United States

Mayo Clinic Cancer Center Rochester, Minnesota, United States

View Trial Details

Completed

Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple Myeloma

NCT00317798

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chemically-Induced Disorders, +16 more
Locations: James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States

View Trial Details

Completed

Radiation Therapy and Cyclophosphamide Plus Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

NCT00004908

Conditions: Chronic Disease, Dendritic Cell Sarcoma, Interdigitating, Disease Attributes, +25 more
Locations: Robert H. Lurie Comprehensive Cancer Center, Northwestern University Chicago, Illinois, United States

View Trial Details

Lymphoproliferative Disorders

Lymphoproliferative Disorders trial results

Related conditions